Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
July 4, 2018
[Radical surgery combined with adjuvant radiotherapy for elderly patients aged over 75 years with stage II( or III( rectal cancer: a retrospective study from a single center]
Wenyang Liu, Jing Jin, Yexiong Li, et al.
International Immunopharmacology
|
October 14, 2025
Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter study
Nuo Yu, Cheng Chen, Xiaomin Wang, et al.
Cancer Research
|
April 18, 2013
DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer
Jianzhong Cao, Yongmei Song, Nan Bi, et al.
Cancer Biology & Therapy
|
October 27, 2024
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
Xin Wang, Guojie Feng, Xiongtao Yang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 12, 2024
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study
Nuo Yu, Xiankai Chen, Jiao Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer
Tao Zhang, Wenji Xue, Daquan Wang, et al.
Cancer Biology & Therapy
|
May 14, 2025
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study
Xiongtao Yang, Xiaomin Wang, Qin Xiao, et al.
BMC Cancer
|
September 23, 2020
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol
Lin-Rui Gao, Xin Wang, Weiming Han, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
September 29, 2021
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
Ning Li, Xin Wang, Yuan Tang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 14, 2024
Postoperative chemoradiotherapy with capecitabine and oxaliplatin <i>vs.</i> capecitabine for pathological stage N2 rectal cancer
Ning Li, Yuan Zhu, Luying Liu, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
July 4, 2018
[Radical surgery combined with adjuvant radiotherapy for elderly patients aged over 75 years with stage II( or III( rectal cancer: a retrospective study from a single center]
Wenyang Liu, Jing Jin, Yexiong Li, et al.
International Immunopharmacology
|
October 14, 2025
Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter study
Nuo Yu, Cheng Chen, Xiaomin Wang, et al.
Cancer Research
|
April 18, 2013
DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer
Jianzhong Cao, Yongmei Song, Nan Bi, et al.
Cancer Biology & Therapy
|
October 27, 2024
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
Xin Wang, Guojie Feng, Xiongtao Yang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 12, 2024
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study
Nuo Yu, Xiankai Chen, Jiao Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer
Tao Zhang, Wenji Xue, Daquan Wang, et al.
Cancer Biology & Therapy
|
May 14, 2025
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study
Xiongtao Yang, Xiaomin Wang, Qin Xiao, et al.
BMC Cancer
|
September 23, 2020
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol
Lin-Rui Gao, Xin Wang, Weiming Han, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
September 29, 2021
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
Ning Li, Xin Wang, Yuan Tang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 14, 2024
Postoperative chemoradiotherapy with capecitabine and oxaliplatin <i>vs.</i> capecitabine for pathological stage N2 rectal cancer
Ning Li, Yuan Zhu, Luying Liu, et al.
Page
of 8